MusclePharm (OTCMKTS:MSLP) Share Price Crosses Below 200 Day Moving Average of $0.16
MusclePharm (OTCMKTS:MSLP) Share Price Crosses Below 200 Day Moving Average of $0.16
MusclePharm Co. (OTCMKTS:MSLP – Get Rating)'s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.16 and traded as low as $0.01. MusclePharm shares last traded at $0.01, with a volume of 145 shares.
在週四的交易中,MusclePharmCo.的股價跌破了200日移動均線,200日移動均線切入位為0.16美元,最低交易價格為0.01美元。MusclePharm股價最新報0.01美元,成交量為145股。
MusclePharm Stock Performance
MusclePharm股票表現
The business has a fifty day simple moving average of $0.11 and a 200 day simple moving average of $0.16. The company has a market cap of $206,993.20, a P/E ratio of -0.01 and a beta of -0.07.
該業務的50日簡單移動均線切入位為0.11美元,200日簡單移動均線切入位為0.16美元。該公司市值為206,993.20美元,本益比為-0.01,貝塔係數為-0.07。
MusclePharm Company Profile
MusclePharm公司簡介
(Get Rating)
(獲取評級)
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.
公司在美國和國際上開發、製造、營銷和分銷運動營養品和營養補充劑。該公司提供一系列高性能粉末、膠囊、片劑、凝膠和隨時可用的零食。該公司的MusclePharm品牌產品組合包括戰鬥蛋白粉和戰鬥擠壓蛋白棒;以及支鏈胺基酸、肌酸、谷氨醯胺、肉鹼、共軛亞油酸、魚油、多種維生素和其他產品等基本補充劑。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
- Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
- This Is Why Daktronics Fell 40% In One Day
- Is It Time To Throw In The Towel On Gamestop?
- Why You Should Avoid Carvana Even if it Avoids Bankruptcy
- Are Investors Hearing The End Of Spotify's Downtrend?
- 免費獲取StockNews.com關於MusclePharm的研究報告(MSLP)
- 輝瑞、強生能否繼續跑贏該指數?
- 這就是為什麼達科電子在一天內下跌了40%
- 是時候在Gamestop上認輸了嗎?
- 為什麼你應該避免Carvana,即使它可以避免破產
- 投資者是否聽到了Spotify下跌趨勢的終結?
Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.
接受MusclePharm日報的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊收到對MusclePharm和相關公司的最新新聞和分析師評級的每日簡要摘要。